John H True, MD | |
1800 W 1st St, Suite 107b, Elk City, OK 73644-3133 | |
(580) 225-9988 | |
(580) 225-5423 |
Full Name | John H True |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1800 W 1st St, Elk City, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548200223 | NPI | - | NPPES |
P00209413 | Other | OK | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 24124 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
John H True, MD 220 Ridgecrest Dr, #l154, Elk City, OK 73644-1947 Ph: (580) 303-0225 | John H True, MD 1800 W 1st St, Suite 107b, Elk City, OK 73644-3133 Ph: (580) 225-9988 |
News Archive
US-based Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has launched a regional distribution hub in Singapore to address strong customer demand in the Asia Pacific regions of India, China, Taiwan, Hong Kong, Korea, South East Asia, Australia and New Zealand.
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
Canadian Pacific and the Heart and Stroke Foundation today are teaming up to save lives and improve the health of all Canadians through the funding of research excellence in Canada. The commitment of $3 million over three years towards cardiac research represents the largest partnership in the Foundation's history.
Stratum Benefit Solutions has launched Corporate Health IQ™, a 360-degree corporate health risk assessment and comprehensive strategy for designing and implementing integrated results-based incentives for corporate health and wellness programs.
Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin, vinblastine and dacarbazine chemotherapy, which is the standard of care.
› Verified 7 days ago
Steven Riley Winham, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1710 W 3rd St, Elk City, OK 73644 Phone: 580-339-7540 |